Former Head of China’s Traditional Chinese Medicine Administration Yu Yanhong Under Investigation

The voluntary surrender is the detail that carries weight here: it suggests the case is already well-developed rather than freshly opened, and that cooperation is being factored in from the outset. For the traditional Chinese medicine sector, which sits at the intersection of health policy, state-backed promotion and commercial licensing, the exposure is less about one official than about the review touching an agency whose remit has expanded steadily. Whether the investigation stays confined to Yu or widens into the TCM approval and promotion apparatus is the open question worth watching.